The European Society of Surgical Oncology (ESSO) invites clinicians involved in the care of patients with neuroendocrine tumours (NETs) to participate in a survey exploring current treatment practices and perceptions of Peptide Receptor Radionuclide Therapy (PRRT). The survey aims to provide valuable insights into how NETs are managed across different settings and specialties, helping to identify trends, challenges, and opportunities for improving patient care. We welcome responses from surgeons and other cancer-treating professionals, including both trainees and fully qualified specialists.
The survey is anonymous, does not collect personally identifiable information, and takes approximately 8 minutes to complete. Your contribution will help improve future discussions and initiatives in NET management.
